The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype
- 31 March 2009
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 43 (6), 642-648
- https://doi.org/10.1016/j.jpsychires.2008.09.001
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysisBehavioral and Brain Functions, 2007
- Serotonin Function in Panic Disorder: Important, But Why?Neuropsychopharmacology, 2005
- Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter GeneNeuropsychopharmacology, 2005
- Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorderAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2004
- Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled StudyNeuropsychopharmacology, 2002
- Cholecystokinin and panic disorder: Past and future clinical research strategiesScandinavian Journal of Clinical and Laboratory Investigation, 2001
- Evaluating gene × psychological risk factor effects in the pathogenesis of anxiety: A new model approach.Journal of Abnormal Psychology, 2000
- Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmissionJournal of Psychopharmacology, 1997
- Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus mazeNeuropharmacology, 1994
- Anxiety sensitivity, anxiety frequency and the prediction of fearfulnessBehaviour Research and Therapy, 1986